share_log

HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on CollPlant Biotechnologies, Maintains $11 Price Target

HC Wainwright & Co.重申买入CollPlant Biotechnologies,维持11美元的目标价
Benzinga ·  2023/08/25 18:07

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $11 price target.

HC Wainwright&Co.分析师Swayampakula Ramakanth重申科尔植物生物技术公司(纳斯达克:CLGN)的买入,并维持11美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发